Intangible Assets, net and Goodwill (Details Textual) - USD ($) |
3 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2022 |
Mar. 31, 2022 |
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Finite-Lived Intangible Assets [Line Items] | ||||
| Goodwill asset | $ 5,600,000 | $ 5,100,000 | ||
| Goodwill impairment loss | 31,135,994 | 14,354,114 | ||
| Impairment Adjustment | $ 11,900,000 | $ 15,400,000 | 14,400,000 | |
| Capitalized software costs | 2,700,000 | $ 5,600,000 | ||
| Solo Sciences (“Solo”), Viridian Sciences Inc. (“Viridian”) and Trellis Solutions (“Trellis”) [Member] | ||||
| Finite-Lived Intangible Assets [Line Items] | ||||
| Intangible asset charge | $ 3,800,000 | |||
| X | ||||||||||
- Definition Accumulated amount of amortization expenses of assets, excluding financial assets and goodwill, lacking physical substance with a finite life. No definition available.
|
| X | ||||||||||
- Definition The amount of impairment to goodwill. No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill. No definition available.
|
| X | ||||||||||
- Definition Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|